BACKGROUND: The effect of mild chronic kidney disease (CKD) on depression, stress, quality of life (QOL), and health status is not well understood. We compared these outcomes in subjects with and without CKD. METHODS: We performed a cross-sectional study of 967 outpatients enrolled in the Heart and Soul Study. CKD was defined as a measured creatinine clearance < 60 ml/min. Outcome measures included depressive symptoms measured using the Patient Health Questionnaire (PHQ), stress measured using the Perceived Stress Scale (PSS), and QOL and overall health rated as excellent, very good, good, fair, or poor. RESULTS: The prevalence of depressive symptoms (17 vs. 19%, p = 0.4) or perceived stress (11 vs. 16%, p = 0.09) did not vary significantly by CKD. The prevalence of fair or poor QOL was not significantly different in subjects with CKD, compared with those without CKD (24 vs. 23%, p = 0.65). Age-adjusted analyses revealed a significant association of CKD with QOL (p = 0.003), however, this association no longer reached statistical significance after adjustment for confounders (p = 0.06). Subjects with CKD were more likely to report poor or fair overall health than subjects without CKD (42 vs. 34%, p = 0.03). After multivariate adjustment, CKD remained significantly associated with worse overall health (OR = 1.65, 95% CI 1.21-2.24, p = 0.001), and modestly associated with QOL (OR = 1.31, 95% CI 0.99-1.75, p = 0.06), but had no association with depression (p = 0.48) or stress (p = 0.24). CONCLUSION: In this study of persons with coronary artery disease, subjects with CKD had reduced overall health and modestly reduced QOL; however, mental health was similar in those with and without CKD. These findings suggest that self- assessed overall health may decline at earlier stages of renal dysfunction than mental health outcomes or QOL. 2006 S. Karger AG, Basel.
BACKGROUND: The effect of mild chronic kidney disease (CKD) on depression, stress, quality of life (QOL), and health status is not well understood. We compared these outcomes in subjects with and without CKD. METHODS: We performed a cross-sectional study of 967 outpatients enrolled in the Heart and Soul Study. CKD was defined as a measured creatinine clearance < 60 ml/min. Outcome measures included depressive symptoms measured using the Patient Health Questionnaire (PHQ), stress measured using the Perceived Stress Scale (PSS), and QOL and overall health rated as excellent, very good, good, fair, or poor. RESULTS: The prevalence of depressive symptoms (17 vs. 19%, p = 0.4) or perceived stress (11 vs. 16%, p = 0.09) did not vary significantly by CKD. The prevalence of fair or poor QOL was not significantly different in subjects with CKD, compared with those without CKD (24 vs. 23%, p = 0.65). Age-adjusted analyses revealed a significant association of CKD with QOL (p = 0.003), however, this association no longer reached statistical significance after adjustment for confounders (p = 0.06). Subjects with CKD were more likely to report poor or fair overall health than subjects without CKD (42 vs. 34%, p = 0.03). After multivariate adjustment, CKD remained significantly associated with worse overall health (OR = 1.65, 95% CI 1.21-2.24, p = 0.001), and modestly associated with QOL (OR = 1.31, 95% CI 0.99-1.75, p = 0.06), but had no association with depression (p = 0.48) or stress (p = 0.24). CONCLUSION: In this study of persons with coronary artery disease, subjects with CKD had reduced overall health and modestly reduced QOL; however, mental health was similar in those with and without CKD. These findings suggest that self- assessed overall health may decline at earlier stages of renal dysfunction than mental health outcomes or QOL. 2006 S. Karger AG, Basel.
Authors: Michael J Fischer; Paul L Kimmel; Tom Greene; Jennifer J Gassman; Xuelei Wang; Deborah H Brooks; Jeanne Charleston; Donna Dowie; Denyse Thornley-Brown; Lisa A Cooper; Marino A Bruce; John W Kusek; Keith C Norris; James P Lash Journal: Kidney Int Date: 2011-06-01 Impact factor: 10.612
Authors: Michael J Fischer; Paul L Kimmel; Tom Greene; Jennifer J Gassman; Xuelei Wang; Deborah H Brooks; Jeanne Charleston; Donna Dowie; Denyse Thornley-Brown; Lisa A Cooper; Marino A Bruce; John W Kusek; Keith C Norris; James P Lash Journal: Kidney Int Date: 2010-03-03 Impact factor: 10.612
Authors: Kellie Hunter Campbell; Elbert S Huang; William Dale; Melissa M Parker; Priya M John; Bessie A Young; Howard H Moffet; Neda Laiteerapong; Andrew J Karter Journal: Am J Kidney Dis Date: 2013-06-05 Impact factor: 8.860
Authors: Evgueni Minev; Mark Unruh; Michael G Shlipak; Eleanor Simsonick; Kristine Yaffe; Tennille S Leak; Anne B Newman; Linda F Fried Journal: Nephron Clin Pract Date: 2010-07-02
Authors: Michael J Fischer; Dawei Xie; Neil Jordan; Willem J Kop; Marie Krousel-Wood; Manjula Kurella Tamura; John W Kusek; Virginia Ford; Leigh K Rosen; Louise Strauss; Valerie L Teal; Kristine Yaffe; Neil R Powe; James P Lash Journal: Am J Kidney Dis Date: 2012-04-11 Impact factor: 8.860
Authors: Maria-Eleni Roumelioti; Christos Argyropoulos; Daniel J Buysse; Harry Nayar; Steven D Weisbord; Mark L Unruh Journal: Nephron Clin Pract Date: 2010-01-20
Authors: John A Spertus; Philip G Jones; David J Maron; Daniel B Mark; Sean M O'Brien; Jerome L Fleg; Harmony R Reynolds; Gregg W Stone; Mandeep S Sidhu; Bernard R Chaitman; Glenn M Chertow; Judith S Hochman; Sripal Bangalore Journal: N Engl J Med Date: 2020-03-30 Impact factor: 91.245